Professor James Flanagan, Imperial College, London, on the CLOCS project and how data sharing of transactions could speed up cancer diagnosis. The first CLOCS project showed that ovarian cancer ...

New science and technology can transform healthcare, offering exciting opportunities for better and more personalised prediction, prevention and treatment of disease. Our primary focus continues to be ...

The UK is a recognised powerhouse for genomic science and medicine. Genomics England’s 100,000 Genomes Project is the largest sequencing project of its kind in the world and, building on these ...

We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...

The European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel? The Regulation amounts to an ambitious and laudable step ...

The GenomeIndia Project, launched in 2020, represents a strategic effort to map India’s vast genetic diversity. It focuses on India’s rich tapestry of ethnolinguistic communities (Indo-European, ...

With the current pandemic of bird flu – avian influenza – there is a growing concern around diseases spilling over from animals to humans. The COVID-19 pandemic highlighted the devastating impact such ...

It is no secret that the AI regulatory landscape has experienced monumental shifts in the last six months. Rhetoric that views regulation as a barrier to AI innovation and the cross-sectoral ...

These plans have been a long time in the making. The intention to produce a strategy ‘to ensure the UK is able to offer a predictive, preventative and personalised health and care service for people ...

Polygenic scores aim to measure the cumulative effect of multiple genetic variants to make predictions about a person’s health. The most likely areas of potential use are in risk prediction, including ...